Abbott Laboratories news

   Watch this stock
Showing stories 1 - 10 of about 116   

Articles published

ABT 46.25 -0.27 (-0.58%)
price chart
Abbott Labs Files to Sell Nearly a Third of Its Mylan Stake
The companies in July said Mylan would buy Abbott's drug portfolio in developed overseas markets, in a $5.3 billion deal that would allow Mylan to benefit from a lower tax rate by organizing the new company in the Netherlands.
Why Did Abbott Ditch 35 Million Mylan Shares? (ABT, MYL)  Investorplace.com
Mylan Finds Support After Abbott Labs Offering Tumble MYL ABT  Investor's Business Daily
How Abbott Labs is crushing it in Asia
Amid the stampede of Western multinationals pushing to expand in China and India, a few are way out ahead of the pack. Take Abbott Laboratories (No. 136 on the Fortune 500), for instance. The Illinois-based maker of nutritional products and medical ...
Abbott Labs, Sekisui Medical to Offer Coagulation Tests
Abbott Labs expects that sales of the CP3000 will begin later in Europe, countries that recognize CE Mark and non-regulated countries in 2015, and in the U.S.
Abbott Laboratories Given AA- Credit Rating by Morningstar (ABT)  sleekmoney
Zacks Short Term Rating on Abbott Laboratories (NYSE:ABT)  Trade Journo
Abbott Laboratories, AbbVie Inc Will Be Tried for Off-Label Depakote Marketing ...
Back in 2012 Abbott Laboratories found itself subject to criminal and civil charges by the US Justice Department. This involved the illegal promotion of the Abbott's drug Depakote; for uses not approved by the US Food and Drug Administration (FDA).
Abbott, Abbvie Face Renewed Depakote Marketing Class Action  The Am Law Litigation Daily
Abbott Laboratories: A Great Long-Term Investment (ABT)
Abbott Laboratories also has a broad and balanced portfolio, with Medical Devices representing 27% of sales, Established Pharmaceuticals representing 16% of sales, Diagnostics representing 23% of sales, and Nutrition representing 34% of sales.
Ex-Dividend Reminder: AbbVie, Abbott Laboratories and Pennymac Mortgage ...
Looking at the universe of stocks we cover at Dividend Channel, on 4/13/15, AbbVie Inc. (NYSE: ABBV), Abbott Laboratories (NYSE: ABT), and Pennymac Mortgage Investment Trust (NYSE: PMT) will all trade ex-dividend for their respective upcoming ...
Abbott Laboratories (ABT) To Sell Off A Third of Its Stake In Mylan
Abbott Laboratories (NYSE:ABT) plans to offer almost 32% of its stake in Mylan NV (NASDAQ:MYL), only after a week after Mylan bought a drug portfolio from Abbott in exchange for stock worth $5.3 billion.
Mylan N.V. Announces Pricing of Secondary Public Offering of a Portion of ...  PR Newswire (press release)
Hot Stocks Early Moves - United Continental Holdings, (NYSE:UAL), Mylan N.V. ...  wsnewspublishers
Investor Insights on Abbott Laboratories (NYSE:ABT)
[PRNewswire] Abbott Laboratories (NYSE:ABT)(TREND ANALYSIS), About three years ago, Betty Vaughn of Golden Valley, Minn., started to feel light-headed, fatigued and out of breath when she walked up and down the stairs.
Insider Selling: Broadcom Corporation (BRCM), Abbott Laboratories (ABT ...  Bidness ETC
Stock Insights on Abbott Laboratories (NYSE:ABT)  Investor Newswire
Form SC 13D/A Mylan NV Filed by: ABBOTT LABORATORIES
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of ��240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box o.
RICO Claims Against Abbott Labs Revived
CHICAGO (CN) - Originally dismissed as untimely, the 7th Circuit has revived RICO claims against Abbott Labs for promoting anti-seizure drug Depakote for off-label uses.